Delaney G, Jacob S, Featherstone C, Barton M. The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer. 2005;104:1129–37. https://doi.org/10.1002/cncr.21324.
Begg AC, Stewart FA, Vens C. Strategies to improve radiotherapy with targeted drugs. Nat Rev Cancer. 2011;11:239–53. https://doi.org/10.1038/nrc3007.
Article CAS PubMed Google Scholar
Barnett GC, West CM, Dunning AM, Elliott RM, Coles CE, Pharoah PD, Burnet NG. Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype. Nat Rev Cancer. 2009;9:134–42. https://doi.org/10.1038/nrc2587.
Article CAS PubMed PubMed Central Google Scholar
Schmal Z, Isermann A, Hladik D, von Toerne C, Tapio S, Rübe CE. DNA damage accumulation during fractionated low-dose radiation compromises hippocampal neurogenesis. Radiother Oncol. 2019;137:45–54. https://doi.org/10.1016/j.radonc.2019.04.021.
Article CAS PubMed Google Scholar
Kempf SJ, Moertl S, Sepe S, von Toerne C, Hauck SM, Atkinson MJ, Mastroberardino PG, Tapio S. Low-dose ionizing radiation rapidly affects mitochondrial and synaptic signaling pathways in murine hippocampus and cortex. J Proteome Res. 2015;14(5):2055–64. https://doi.org/10.1021/acs.jproteome.5b00114.
Article CAS PubMed Google Scholar
Parihar VK, Limoli CL. Cranial irradiation compromises neuronal architecture in the hippocampus. PNAS. 2013;220(31):12822–7. https://doi.org/10.1073/pnas.1307301110.
Tan YF, Rosenzweig S, Jaffray D, Wojtowicz JM. Depletion of new neurons by image guided irradiation. Front Neurosci. 2011;5:59. https://doi.org/10.3389/fnins.2011.00059.
Article PubMed PubMed Central Google Scholar
Dzierma Y, Schuermann M, Melchior P, Nuesken F, Oertel J, Rübe C, Hendrix Ph. Optimizing adjuvant stereotactic radiotherapy of motor-eloquent brain metastases: sparing the nTMS-defined motor cortex and the hippocampus. Front Oncol. 2021;11:628007. https://doi.org/10.3389/fonc.2021.628007.
Article PubMed PubMed Central Google Scholar
Gondi V, Pugh SL, Tome WA, Caine C, Corn B, Kanner A, Rowley H, Kundapur V, DeNittis A, Greensppon JN, Konski AA, Bauman GS, Shah S, Shi W, Wendland M, Kachnic L, Mehta MP. Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial. J Clin Oncol. 2014;32(34):3810–6. https://doi.org/10.1200/JCO.2014.57.2909.
Article PubMed PubMed Central Google Scholar
Tsai P-F, Yang C-C, Chuang C-C, Huang T-Y, Wu Y-M, Pai P-C, Tseng C-K, Wu T-H, Shen Y-L, Lin S-Y. Hippocampal dosimetry correlates with the change in neurocognitive function after hippocampal sparing during whole brain radiotherapy: a prospective study. Radiat Oncol. 2015;10:253. https://doi.org/10.1186/s13014-015-0562-x.
Article CAS PubMed PubMed Central Google Scholar
Birer SR, Olson AC, Adamson J, Hood R, Susen M, Kim G, Salama JK, Kirkpatrick JP. Hippocampal dose from stereotactic radiosurgery for 4 to 10 brain metastases: risk factors, feasibility of dose reduction via re-optimization, and patient outcomes. Med Dosim. 2017;42(4):310–6. https://doi.org/10.1016/j.meddos.2017.06.007.
Kim KS, Wee CW, Seok J-Y, Hong JW, Chung J-B, Kim E-Y, J-S, Kim C-Y, Park YH, Kim YJ, Kim IA,. Hippocampus-sparing radiotherapy using volumetric modulated arc therapy (VMAT) to the primary brain tumor: the result of dosimetric study and neurocognitive function assessment. Radiat Oncol. 2018;13(1):29. https://doi.org/10.1186/s13014-018-0975-4.
Article PubMed PubMed Central Google Scholar
Sun Z-W, Shi L, Li Q, Kong Y, Du F-L, Xie T-m, Hua Y-h, Hu Q-y, Chen X-z, Chen Y-y, Chen M. Results of the radiation dose of head, body and tail of hippocampus in nasopharyngeal carcinoma patients treated with intensity modulated radiotherapy. Sci Rep. 2018;8:5595. https://doi.org/10.1038/s41598-018-23127-6.
Khodayari B, Michaud AL, Stanic S, Wooten OH, Dublin A, Purdy JA, Chen AM. Evaluation of hippocampus dose for patients undergoing intensity-modulated radiotherapy for nasopharyngeal carcinoma. Br J Radiol. 2014;87(1037):20130474. https://doi.org/10.1259/bjr.20130474.
Article CAS PubMed PubMed Central Google Scholar
Alghamdi S, Tajaldeen A. Evaluation of dose calculation algorithms using different density materials for in-field and out-of-field conditions. Exp Oncol. 2019;41(1):46–52.
Wang L, Ding GX. The accuracy of the out-of-field dose calculations using a model based algorithm in a commercial treatment planning system. Phys Med Biol. 2014;59:N113–28. https://doi.org/10.1088/0031-9155/59/13/n113.
Jang SY, Liu HH, Mohan R. Underestimation of low-dose radiation in treatment planning of intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2008;71(5):1537–46. https://doi.org/10.1016/j.ijrobp.2008.04.014.
Huang JY, Followill DS, Wang XA, Kry SF. Accuracy and sources of error of out-of field dose calculations by a commercial treatment planning system for intensity-modulated radiation therapy treatments. J Appl Clin Med Phys. 2013;14(2):186–97. https://doi.org/10.1120/jacmp.v14i2.4139.
Article PubMed Central Google Scholar
Howell RM, Scarboro SB, Kry SF, Yaldo DZ. Accuracy of out-of-field dose calculations by a commercial treatment planning system. Phys Med Biol. 2010;55:6999–7008. https://doi.org/10.1088/0031-9155/55/23/S03.
Article PubMed PubMed Central Google Scholar
Sadrollahi A, Nuesken F, Licht N, Rübe C, Dzierma Y. Monte-Carlo simulation of the Siemens Artiste linear accelerator 6 MV and flattening-filter-free 7 MV beam line. PLoS ONE. 2019;14(1):e0210069. https://doi.org/10.1371/journal.pone.0210069.
Article CAS PubMed PubMed Central Google Scholar
Marks LB, Yorke ED, Jackson A, Ten Haken RK, Constine LS, Eisbruch A, Bentzen SM, Nam J, Deasy JO. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S10–9. https://doi.org/10.1016/j.ijrobp.2009.07.1754.
Article PubMed PubMed Central Google Scholar
Eekers DB, Ven LI, Roelofs E, Postma A, Alapetite C, Burnet NG, Calugaru V, Compter I, Coremans IEM, Høyer M, Lambrecht M, Nyström PW, Méndez-Romero A, Paulsen F, Perpar A, de Ruysscher D, Renard L, Timmermann B, Vitek P, Weber DC, van der Weide H, Whitfield GA, Wiggenraad R, Troost EGC. European particle therapy network of ESTRO. The EPTN consensus-based atlas for CT- and MR- based contouring in neuro-oncology. Radiother Oncol. 2018;128(1):37–43. https://doi.org/10.1016/j.radonc.2017.12.013.
Scoccianti S, Detti B, Gadda D, Greto D, Furfaro I, Meacci F, Simontacchi G, Di Brina L, Bonomo P, Giacomelli I, Meattini I, Mangoni M, Capelli S, Cassani S, Talamonti C, Bordi L, Livi L. Organs at risk in the brain and their dose-constraints in adults and in children: a radiation oncologists’s guide for delineation in everyday practice. Radiother Oncol. 2015;114(2):P230-238. https://doi.org/10.1016/j.radonc.2015.01.016.
Dzierma Y, Nuesken F. Of Mice and men: applications of thermoluminescent dosimetry. In: Chan MF, editor. Recent advancements and Applications in Dosimentry. Hauppauge: Nova Science Publishers, Inc; 2018. p. 251–70.
Dzierma Y, Nuesken F, Otto W, Alaei P, Licht N, Rübe C. Dosimetry of an in-line kilovoltage imaging system and implementation in treatment planning. Int J Radiat Oncol Biol Phys. 2014;88(4):913–9. https://doi.org/10.1016/j.ijrobp.2013.12.007.
Harrison R. Out-of-field doses in radiotherapy: input to epidemiological studies and dose-risk models. Phys Med. 2017;42:239–46. https://doi.org/10.1016/j.ejmp.2017.02.001.
Sanchez-Nieto B, Medina-Ascanio KN, Rodriguez-Mongua JL, Doerner E, Espinoza I. Study of out-of-field dose in photon radiotherapy: a commercial treatment planning system versus measurements and Monte Carlo simulations. Med Phys. 2020;47(9):4616–25. https://doi.org/10.1002/mp.14356.
Article CAS PubMed Google Scholar
Fogliata A, Clivio A, Vanetti E, Nicolini G, Belosi MF, Cozzi L. Dosimetric evaluation of photon dose calculation under jaw and MLC shielding. Med Phys. 2013. https://doi.org/10.1118/1.4820443.
Ruben JD, Craig M, Lancester CM, Jones P, Smith RL. A comparison of out-of-field dose and its constituent components for intensity-modulated radiation therapy versus conformal radiation therapy: implications for carcinogenesis. Int J Radiat Oncol Biol Phys. 2011;81(5):1458–64. https://doi.org/10.1016/j.ijrobp.2010.08.008.
Kruszyna M, Adamczyk S, Skrobała A, Skórska M, Suchorska W, Zaleska K, Kowalik A, Jackowiak W, Malicki J. Low dose out-of-field radiotherapy, part 1: measurement of scattered doses. Cancer/Radiothérapie. 2017;21:345–51. https://doi.org/10.1016/j.canrad.2016.09.017.
Article CAS PubMed Google Scholar
Powell C, Schick U, Morden JP, Gulliford SL, Miah AB, Bhide S, Newbold K, Harrington KJ, Nutting CM. Fatigue during chemoradiotherapy for nasopharyngeal cancer and its relationship to radiation dose distribution in the brain. Radiother Oncol. 2014;110:416–21. https://doi.org/10.1016/j.radonc.2013.06.042.
Dunlop A, Welsh L, McQuaid D, Dean J, Gulliford S, Hansen V, Bhide S, Nutting C, Harrington K, Newbold K. Brain-sparing methods for IMRT of head and neck cancer. PLoS ONE. 2015;10(3):e0120141. https://doi.org/10.1371/journal.pone.0120141.
Article CAS PubMed PubMed Central Google Scholar
Shi L, Du FL, Sun ZW, Zhang L, Chen YY, Xie TM, Li PJ, Huang S, Dong BQ, Zhang MM. Radiation-induced gray matter atrophy in patients with nasopharyngeal carcinoma after intensity modulated radiotherapy: a MRI magnetic resonance imaging voxel-based morphometry study. Quant Imaging Med Surg. 2018;8(9):902–9. https://doi.org/10.21037/qims.2018.10.09.
Article PubMed PubMed Central Google Scholar
Sharma MB, Jensen K, Amidi A, Eskildsen SF, Johansen J, Grau C. Late toxicity in the brain after radiotherapy for sinonasal cancer: neurocognitive functioning, MRI of the brain and quality of life. Clin Transl Radiat Oncol. 2020;25:52–60. https://doi.org/10.1016/j.ctro.2020.09.003.
留言 (0)